-
IntroducedJan 18, 2017
-
Passed House
-
Passed Senate
-
Signed into LawNov 07, 2018
An Act relating to prescribing, dispensing, and administering an investigational drug, biological product, or device by physicians for patients who are terminally ill for the purpose of sustaining the patient's life; providing immunity related to manufacturing, distributing, or providing investigational drugs, biological products, or devices; and relating to licensed health care facility requirements.
Last Action See all actions
House • Nov 07, 2018: (H) EFFECTIVE DATE(S) OF LAW 10/11/18
Latest Bill Text See all bill texts
Official Summary/Bill Text
Comments on HB 43
Tweets
Whip Lists
Sponsors
Votes
Actions
- Nov 07, 2018 | House
- (H) 1:37 PM 7/9/18 Transmitted to Governor
- (H) Signed into law 7/13 CHAPTER 53 SLA 18
- (H) EFFECTIVE DATE(S) OF LAW 10/11/18
- Apr 28, 2018 | House
- (H) MANIFEST ERROR(S)
- Apr 25, 2018 | Senate
- (S) RULES TO CALENDAR 4/25/2018
- (S) Read the second time
- (S) ADVANCED TO THIRD READING UC
- (S) Read the third time CSHB 43(JUD)
- (S) CROSS SPONSOR(S): WIELECHOWSKI, SHOWER, COSTELLO, GIESSEL, BISHOP, MACKINNON
- (S) MICCICHE, GARDNER, HUGHES, BEGICH, EGAN, MEYER
- (S) PASSED Y20 N-
- (S) CROSS SPONSOR(S): VON IMHOF
- (S) RETURN TO (H), TRANSMIT TO GOV NEXT
- (S) VERSION: CSHB 43(JUD)
- Mar 28, 2018 | Senate
- (S) JUD RPT 2DP 3NR
- (S) DP: COGHILL, WIELECHOWSKI
- (S) NR: COSTELLO, KELLY, SHOWER
- (S) FN2: ZERO(CED)
- (S) JUDICIARY at 01:30 PM BELTZ 105 (TSBldg)
- (S)
- (S) Minutes (SJUD)
- Mar 26, 2018 | Senate
- (S) JUDICIARY at 01:30 PM BELTZ 105 (TSBldg)
- (S) Moved CSHB 43(JUD) Out of Committee
- (S) Minutes (SJUD)
- Feb 28, 2018 | Senate
- (S) JUDICIARY at 01:30 PM BELTZ 105 (TSBldg)
- (S) Heard & Held
- (S) Minutes (SJUD)
- Jan 31, 2018 | Senate
- (S) HSS RPT 3DP 1NR
- (S) DP: VON IMHOF, BEGICH, GIESSEL
- (S) NR: MICCICHE
- (S) FN2: ZERO(CED)
- Jan 29, 2018 | Senate
- (S) HEALTH & SOCIAL SERVICES at 01:30 PM BUTROVICH 205
- (S) Moved CSHB 43(JUD) Out of Committee
- (S) Minutes (SHSS)
- Jan 24, 2018 | Senate
- (S) HEALTH & SOCIAL SERVICES at 01:30 PM BUTROVICH 205
- (S) Heard & Held
- (S) Minutes (SHSS)
- Apr 11, 2017 | Senate
- (S) Read the first time - REFERRALS
- (S) HSS, JUD
- Apr 10, 2017 | House
- (H) MOVED TO BOTTOM OF CALENDAR
- (H) MOVED TO BOTTOM OF CALENDAR
- (H) Read the third time CSHB 43(JUD)
- (H) PASSED Y40
- (H) COSPONSOR(S): GUTTENBERG, KNOPP, TARR, JOSEPHSON, TILTON, RAUSCHER
- (H) TRANSMITTED TO (S)
- (H) VERSION: CSHB 43(JUD)
- Apr 09, 2017 | House
- (H) RULES TO CALENDAR 4/9/2017
- (H) Read the second time
- (H) JUD CS ADOPTED UC
- (H) ADVANCED TO THIRD READING 4/10 CALENDAR
- (H) COSPONSOR(S): FANSLER, PARISH
- Apr 05, 2017 | House
- (H) JUD RPT CS(JUD) NT 5DP 1NR
- (H) DP: EASTMAN, KOPP, FANSLER, LEDOUX, CLAMAN
- (H) NR: REINBOLD
- (H) FN1: ZERO(CED)
- (H) COSPONSOR(S): LEDOUX, EASTMAN
- Apr 03, 2017 | House
- (H) JUDICIARY at 01:00 PM GRUENBERG 120
- (H) Moved CSHB 43(JUD) Out of Committee
- (H) Minutes (HJUD)
- Mar 29, 2017 | House
- (H) JUDICIARY at 01:00 PM GRUENBERG 120
- (H) Heard & Held
- (H) Minutes (HJUD)
- Mar 08, 2017 | House
- (H) HSS RPT 5DP 1NR 1AM
- (H) DP: JOHNSTON, TARR, EDGMON, SULLIVAN-LEONARD, SPOHNHOLZ
- (H) NR: KITO
- (H) AM: EASTMAN
- (H) FN1: ZERO(CED)
- Mar 07, 2017 | House
- (H) HEALTH & SOCIAL SERVICES at 03:00 PM CAPITOL 106
- (H) Moved HB 43 Out of Committee
- (H) Minutes (HHSS)
- Mar 02, 2017 | House
- (H) HEALTH & SOCIAL SERVICES at 03:00 PM CAPITOL 106
- (H) Heard & Held
- (H) Minutes (HHSS)
- Feb 28, 2017 | House
- (H) HEALTH & SOCIAL SERVICES at 03:00 PM CAPITOL 106
- (H) Heard & Held
- (H) Minutes (HHSS)
- Jan 18, 2017 | House
- (H) Prefile released 1/13/17
- (H) Read the first time - REFERRALS
- (H) HSS, JUD
Documents
- House Fiscal Note 1 by Commerce, Community & Economic Dev -- Fiscal impact: N (03/08/2017)
- Senate Fiscal Note 2 by Commerce, Community & Economic Dev -- Fiscal impact: N (01/31/2018)
- SENATE JUDICIARY 3/26/2018 (Minutes/Audio/Video)
- SENATE JUDICIARY 2/28/2018 (Minutes/Audio/Video)
- SENATE HEALTH & SOCIAL SERVICES 1/29/2018 (Minutes/Audio/Video)
- SENATE HEALTH & SOCIAL SERVICES 1/24/2018 (Minutes/Audio/Video)
- HOUSE JUDICIARY 4/3/2017 (Minutes/Audio/Video)
- HOUSE JUDICIARY 3/29/2017 (Minutes/Audio/Video)
- HOUSE HEALTH & SOCIAL SERVICES 3/7/2017 (Minutes/Audio/Video)
- HOUSE HEALTH & SOCIAL SERVICES 3/2/2017 (Minutes/Audio/Video)
- HOUSE HEALTH & SOCIAL SERVICES 2/28/2017 (Minutes/Audio/Video)
- SJUD 2/28/2018 -- HB 43 - Sponsor Statement.pdf
- SJUD 2/28/2018 -- HB 43 - Sectional Analysis (ver. J).pdf
- SJUD 2/28/2018 -- HB 43 - Presentation.pdf
- SJUD 2/28/2018 -- HB 43 - Letters of Support.pdf
- SJUD 2/28/2018 -- HB 43 - Explanation of Changes (ver. D to ver. J).pdf
- SJUD 2/28/2018 -- HB 43 - Supporting Document - Letter from Premera.pdf
- SJUD 2/28/2018 -- HB 43 - Supporting Document - Legislative Map.pdf
- SJUD 2/28/2018 -- HB 43 - Supporting Document - Goldwater Institute Patient Stories.pdf
- SJUD 2/28/2018 -- HB 43 - Supporting Document - Goldwater Institute Fact Sheet.pdf
- SJUD 2/28/2018 -- HB 43 - Supporting Document - Clinical Trials in Alaska.pdf
- SJUD 2/28/2018 -- HB 43 - Supporting Document - FDA Drug Review Process.pdf
- SHSS 1/29/2018 -- HB43 ver J.PDF
- SHSS 1/29/2018 -- HB43 Supporting Document - Letters of Support 4.11.17.pdf
- SHSS 1/29/2018 -- HB43 Supporting Document - Legislative Map.pdf
- SHSS 1/29/2018 -- HB43 Supporting Document - Goldwater Institute Patient Stories.pdf
- SHSS 1/29/2018 -- HB43 Supporting Document - Goldwater Institute Fact Sheet.pdf
- SHSS 1/29/2018 -- HB43 Supporting Document - FDA Drug Review Process.pdf
- SHSS 1/29/2018 -- HB43 Supporting Document - Clinical Trials in Alaska.pdf
- SHSS 1/29/2018 -- HB43 Sponsor Statement.pdf
- SHSS 1/29/2018 -- HB43 Sectional Analysis ver J.pdf
- SHSS 1/29/2018 -- HB43 Powerpoint Presentation 1.20.2018.pdf
- SHSS 1/29/2018 -- HB43 Fiscal Note DCCED-CBPL-01-19-18.pdf
- SHSS 1/29/2018 -- HB43 Explanation of Changes D to J.pdf
- SHSS 1/29/2018 -- HB43 Additional Document - Letter from Premera.pdf
- SHSS 1/24/2018 -- HB43 Powerpoint Presentation 1.20.2018.pdf
- SHSS 1/24/2018 -- HB43 Supporting Document - Letters of Support 4.11.17.pdf
- SHSS 1/24/2018 -- HB43 Supporting Document - Legislative Map.pdf
- SHSS 1/24/2018 -- HB43 Supporting Document - Goldwater Institute Patient Stories.pdf
- SHSS 1/24/2018 -- HB43 Supporting Document - Goldwater Institute Fact Sheet.pdf
- SHSS 1/24/2018 -- HB43 Supporting Document - FDA Drug Review Process.pdf
- SHSS 1/24/2018 -- HB43 Supporting Document - Clinical Trials in Alaska.pdf
- SHSS 1/24/2018 -- HB43 Additional Document - Letter from Premera.pdf
- SHSS 1/24/2018 -- HB43 Explanation of Changes D to J.pdf
- SHSS 1/24/2018 -- HB43 Fiscal Note DCCED-CBPL-01-19-18.pdf
- SHSS 1/24/2018 -- HB43 Sectional Analysis ver J.pdf
- SHSS 1/24/2018 -- HB43 Sponsor Statement.pdf
- SHSS 1/24/2018 -- HB43 ver J.PDF
- HJUD 4/3/2017 -- HB043 Amendments #1-2 HJUD Final Votes 4.3.17.pdf
- HJUD 4/3/2017 -- HB043 Amendments #1-2 3.31.17.pdf
- HJUD 3/29/2017 -- HB043 Powerpoint Presentation with Video.pptx
- HJUD 3/29/2017 -- HB43 Additional Document-Powerpoint Presentation 3.27.17.pdf
- HJUD 3/29/2017 -- HB043 Additional Document-Letter from Premera 3.27.17.pdf
- HJUD 3/29/2017 -- HB043 Fiscal Note DCCED-CBPL 3.14.17.pdf
- HJUD 3/29/2017 HJUD 4/3/2017 -- HB043 ver D 3.14.17.PDF
- HJUD 3/29/2017 -- HB043 Supporting Document-Letters and Emails of Support 3.14.17.pdf
- HJUD 3/29/2017 -- HB043 Supporting Document-Legislative Map 3.14.17.pdf
- HJUD 3/29/2017 -- HB043 Supporting Document-Goldwater Institute Patient Stories 3.14.17.pdf
- HJUD 3/29/2017 -- HB043 Supporting Document-Goldwater Institute Fact Sheet 3.14.17.pdf
- HJUD 3/29/2017 -- HB043 Supporting Document-FDA Drug Review Process 3.14.17.pdf
- HJUD 3/29/2017 -- HB043 Supporting Document-Clinical Trials in Alaska 3.14.17.pdf
- HJUD 3/29/2017 -- HB043 Sponsor Statement 3.14.17.pdf
- HJUD 3/29/2017 HJUD 4/3/2017 -- HB043 Sectional Analysis ver D 3.14.17.pdf
- HHSS 3/2/2017 HHSS 3/7/2017 -- HB043 Supporting Document - Goldwater Institute Policy Report.pdf
- HHSS 3/2/2017 HHSS 3/7/2017 -- HB043 Supporting Document - Letters of Support 3.2.17.pdf
- HHSS 2/28/2017 HHSS 3/2/2017 HHSS 3/7/2017 -- HB 43 Powerpoint Presentation.pdf
- HHSS 2/28/2017 HHSS 3/2/2017 HHSS 3/7/2017 -- HB43 Supporting Document - Letters of Support 2.27.17.pdf
- HHSS 2/28/2017 HHSS 3/2/2017 HHSS 3/7/2017 -- HB043 Fiscal Note DCCED--DCBPL 2.28.17.pdf
- HHSS 2/28/2017 HHSS 3/2/2017 HHSS 3/7/2017 -- HB043 ver D 2.22.17.PDF
- HHSS 2/28/2017 HHSS 3/2/2017 HHSS 3/7/2017 -- HB043 Supporting Document - Legislative Map 2.22.17.pdf
- HHSS 2/28/2017 HHSS 3/2/2017 HHSS 3/7/2017 -- HB043 Supporting Document - Goldwater Institute Policy Report Summary 2.22.17.pdf
- HHSS 2/28/2017 HHSS 3/2/2017 HHSS 3/7/2017 -- HB043 Supporting Document - Goldwater Institute Patient Stories 2.22.17.pdf
- HHSS 2/28/2017 HHSS 3/2/2017 HHSS 3/7/2017 -- HB043 Supporting Document - Goldwater Institute Fact Sheet 2.22.17.pdf
- HHSS 2/28/2017 HHSS 3/2/2017 HHSS 3/7/2017 -- HB043 Supporting Document - FDA Drug Review Process 2.22.17.pdf
- HHSS 2/28/2017 HHSS 3/2/2017 HHSS 3/7/2017 -- HB043 Supporting Document - Clinical Trials in Alaska.pdf
- HHSS 2/28/2017 HHSS 3/2/2017 HHSS 3/7/2017 -- HB043 Sponsor Statement 2.22.17.pdf
- HHSS 2/28/2017 HHSS 3/2/2017 HHSS 3/7/2017 -- HB043 Sectional Analysis ver D 2.22.17.pdf